Accumulating evidence shows that KAP1 is intrinsically engaged in several core biological processes pertinent to carcinogenesis, disease progression, therapeutic response, and patient survival, revealing both tumor-promoting and suppressing activities. This evidence concerns the gene TRIM28 and neoplasm.